Achievwin
★★  

US,
2021-07-06 16:37
(1185 d 04:44 ago)

Posting: # 22459
Views: 2,365
 

 BE for a drug dosed on body weight [Study Per­for­mance]

Post reply
Has anyone have experience in designing bioequivalence trial for a (oncology or other) drug which dosing varies with body weight (varying doses)? How do you present PK across subjects receiving varying doses (dose normalize to a bench mark dose? or since BE is based on ratio it has no impact?)

Thanks for any feed back:-|
 
dshah
★★  

India,
2021-07-17 13:46
(1174 d 07:35 ago)

@ Achievwin
Posting: # 22475
Views: 1,791
 

 BE for a drug dosed on body weight

Post reply
Dear Achievwin!
If the study is crossover, then the dose administered would generally be same for that subject and thus we could assume that it would not have any impact.
Regards,
Dshah
 
UA Flag
Activity
 Admin contact
23,240 posts in 4,884 threads, 1,655 registered users;
73 visitors (0 registered, 73 guests [including 6 identified bots]).
Forum time: 21:22 CEST (Europe/Vienna)

The epistemological value of probability theory is based on the fact
that chance phenomena, considered collectively and on a grand scale,
create non-random regularity.    Andrey Kolmogorov

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5